Suprazygomatic maxillary nerve block in septorhinoplasty.

Efficacy of ultrasound-guided suprazygomatic maxillary nerve block on emergence agitation and postoperative analgesia after septorhinoplasty. A prospective randomized trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202008687031377

Enrollment

Registered

2020-08-11

Start date

2020-07-20

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

General anesthesia Group I

suprazygomatic maxillary nerve block

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Sixty patients aged 18-60 years of both gender classified by the American Society of Anesthesiologists as ASA I-II scheduled for elective septorhinoplasty surgery under general anesthesia

Exclusion criteria

Exclusion criteria: patient's refusal body mass index >35 kg/m2 pre-existing neurological disease infection at site of the block coagulopathy allergy to local anesthetics chronic analgesic use inability to express NRS score.

Design outcomes

Primary

Measure	Time frame
the incidence of emergence agitation	—

Secondary

Measure	Time frame
postoperative pain and total postoperative analgesic consumption	—

Countries

Egypt

Contacts

Public ContactMona El Mourad

Assistant Professor of Anesthesia Faculty of Medicine Tanta University

monamorad80@gmail.com0020403317928

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026